文献速递神经肿瘤

颅内孤立性纤维性肿瘤与脑膜瘤长期随访结局的倾向评分匹配研究

Long-term follow-up outcomes in intracranial solitary fibrous tumor compared with meningioma: a propensity score matching study.
PubMed 文献 · J Neurosurg · 2025-08-29

单中心回顾性纳入187例初发颅内孤立性纤维性肿瘤(ISFT)与473例初发脑膜瘤患者,经倾向评分匹配后各187例比较长期术后结局。ISFT组5年随访后无进展生存(PFS)显著更差(p<0.0001),5年后疾病特异性生存(DSS)亦显著更差(p=0.025)。诊断年龄≤57岁、Ki-67指数≤6%、核分裂计数≤15、低WHO级别及接受术后放疗与PFS延长显著相关,并构建了识别ISFT高复发风险患者的预后模型。

要点

  • ISFT术后5年后的PFS和DSS均显著差于脑膜瘤。
  • 诊断年龄≤57岁、Ki-67≤6%、核分裂≤15、低WHO级别及术后放疗与PFS延长相关。
  • 诊断年龄、核分裂计数和术后放疗是PFS的独立预测因素。

核心结论

  • ISFT患者术后长期预后显著差于脑膜瘤患者,受诊断年龄、核分裂计数和术后放疗影响。
  • 所构建预后模型对识别ISFT高复发风险患者、尤其预测术后5年以上PFS表现出色。

研究设计与样本

  • 单中心回顾性研究,纳入2013至2021年接受肿瘤切除的187例初发ISFT和473例初发脑膜瘤患者。
  • 采用倾向评分匹配(PSM)匹配队列,行单因素和多因素Cox回归分析评估预后因素。

主要发现

  • ISFT队列187例(男106例,平均年龄46.6岁),PSM后脑膜瘤队列187例(男95例,平均年龄49.2岁)。
  • ISFT队列5年随访后PFS显著差于脑膜瘤队列(p<0.0001)。
  • 前5年两组DSS无显著差异,5年后ISFT队列DSS显著差于脑膜瘤队列(p=0.025)。
  • 诊断年龄≤57岁、Ki-67指数≤6%、核分裂计数≤15、低WHO级别及接受术后放疗与PFS延长显著相关。
  • 诊断年龄、核分裂计数和术后放疗被确定为预测PFS的独立因素。

关键数值与推荐

  • 诊断年龄≤57岁、Ki-67指数≤6%、核分裂计数≤15、低WHO级别及接受术后放疗与PFS延长显著相关。
  • 诊断年龄、核分裂计数和术后放疗为PFS的独立预测因素。

临床怎么用

  • 对ISFT患者应重视5年后的长期随访,警惕复发和疾病特异性生存恶化。
  • 可依据诊断年龄、核分裂计数和术后放疗等因素评估复发风险并制定个体化随访策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intracranial solitary fibrous tumor (ISFT) is a rare type of neoplasm that resembles meningioma. The authors aimed to compare the long-term postoperative outcomes between patients with ISFT and those with meningioma, and to create a model to identify patients with ISFT who are at high risk of recurrence. METHODS: A total of 187 patients with de novo ISFT and 473 patients with de novo meningioma who underwent tumor resection at a single neurosurgical center from 2013 to 2021 were included in this study. Cohorts were matched using propensity score matching (PSM). Univariate and multivariate Cox regression analyses were performed to evaluate prognostic values of clinicopathological characteristics. RESULTS: The ISFT cohort was comprised of 187 patients (106 male, mean age 46.6 years) and, after PSM, the meningioma cohort was comprised of 187 patients (95 male, mean age 49.2 years) for comparison. The survival analysis showed that the ISFT cohort had significantly worse progression-free survival (PFS) after 5 years of follow-up (p < 0.0001) compared with the meningioma cohort. No significant difference in disease-specific survival (DSS) was observed between the cohorts during the first 5 years. However, beyond 5 years, the ISFT cohort had significantly worse DSS than the meningioma cohort (p = 0.025). Further analysis of prognostic factors revealed that an age at diagnosis ≤ 57 years, Ki-67 index ≤ 6%, mitotic count ≤ 15, low WHO grade, and receiving postoperative radiation therapy (RT) were significantly associated with prolonged PFS. Moreover, age at diagnosis, mitotic count, and postoperative RT were identified as independent factors for predicting PFS. Finally, a prognostic model was constructed to identify patients with ISFT at high risk of recurrence. The model demonstrated excellent predictive performance, particularly for predicting PFS beyond 5 years after surgery. CONCLUSIONS: The long-term prognosis of patients with ISFT was significantly worse compared with that of patients with meningioma after surgery, and this was impacted by age at diagnosis, mitotic count, and undergoing postoperative RT. The prognostic model showed excellent predictive performance for identifying patients with ISFT at high risk of recurrence.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ren L, Deng J, Feng A, et al. Long-term follow-up outcomes in intracranial solitary fibrous tumor compared with meningioma: a propensity score matching study. J Neurosurg. 2025. PMID: 40882230. doi:10.3171/2025.4.JNS242400

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。